Capital Insight Partners’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3,730
Closed -$1.75M 42
2025
Q4
$1.75M Sell
3,730
-118
-3% -$54.8K 0.37% 68
2025
Q3
$1.64M Sell
3,848
-30
-0.8% -$11.6K 0.27% 79
2025
Q2
$1.49M Hold
3,878
0.26% 81
2025
Q1
$1.34M Buy
3,878
+220
+6% +$70.8K 0.23% 81
2024
Q4
$1.1M Buy
3,658
+477
+15% +$167K 0.19% 90
2024
Q3
$1.29M Buy
3,181
+120
+4% +$43.9K 0.23% 86
2024
Q2
$983K Buy
+3,061
New +$995K 0.19% 93

Other funds holding HCA

Capital Insight Partners's HCA Position: Q1 2026 in Review

Capital Insight Partners sold out of HCA Healthcare (HCA) in Q1 2026, closing a stake of 3,730 shares — an estimated $1.75M sold.

Capital Insight Partners first reported a position in HCA in Q2 2024 and held it in 7 quarters. The position peaked at $1.75M in Q4 2025. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

  • Capital Insight Partners reported no remaining HCA Healthcare position as of Q1 2026 after selling out during the quarter.
  • Capital Insight Partners sold 3,730 HCA Healthcare shares in Q1 2026, an estimated $1.75M.
  • Capital Insight Partners first reported a position in HCA Healthcare in Q2 2024 and held it in 7 quarters.
  • Capital Insight Partners's HCA Healthcare position peaked at $1.75M in Q4 2025.
  • 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on Capital Insight Partners's 13F filing for Q1 2026.